ATE433461T1 - Rana pipiens proteine und deren verwendung in der behandlung von tumoren - Google Patents

Rana pipiens proteine und deren verwendung in der behandlung von tumoren

Info

Publication number
ATE433461T1
ATE433461T1 AT99968949T AT99968949T ATE433461T1 AT E433461 T1 ATE433461 T1 AT E433461T1 AT 99968949 T AT99968949 T AT 99968949T AT 99968949 T AT99968949 T AT 99968949T AT E433461 T1 ATE433461 T1 AT E433461T1
Authority
AT
Austria
Prior art keywords
proteins
rana
pipien
tumors
treatment
Prior art date
Application number
AT99968949T
Other languages
English (en)
Inventor
Wojciech Ardelt
Original Assignee
Alfacell Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alfacell Corp filed Critical Alfacell Corp
Application granted granted Critical
Publication of ATE433461T1 publication Critical patent/ATE433461T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases [RNase]; Deoxyribonucleases [DNase]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/463—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from amphibians
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT99968949T 1998-12-30 1999-12-24 Rana pipiens proteine und deren verwendung in der behandlung von tumoren ATE433461T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/223,118 US6239257B1 (en) 1998-12-30 1998-12-30 Family of proteins belonging to the pancreatic ribonuclease a superfamily
PCT/US1999/030799 WO2000040608A1 (en) 1998-12-30 1999-12-24 Proteins from rana pipiens and their use in the treatment of tumors

Publications (1)

Publication Number Publication Date
ATE433461T1 true ATE433461T1 (de) 2009-06-15

Family

ID=22835123

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99968949T ATE433461T1 (de) 1998-12-30 1999-12-24 Rana pipiens proteine und deren verwendung in der behandlung von tumoren

Country Status (6)

Country Link
US (1) US6239257B1 (de)
EP (1) EP1141004B1 (de)
JP (1) JP4516216B2 (de)
AT (1) ATE433461T1 (de)
DE (1) DE69940980D1 (de)
WO (1) WO2000040608A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7229824B2 (en) * 2003-07-17 2007-06-12 Alfacell Corporation Ribonucleases and methods of making them recombinantly
WO2006138558A2 (en) * 2005-06-16 2006-12-28 Wisconsin Alumni Research Foundation Cytotoxic ribonuclease variants
JP5114392B2 (ja) 2005-06-16 2013-01-09 ウイスコンシン アラムニ リサーチ ファンデーション 細胞傷害性リボヌクレアーゼ変異株
CN100372869C (zh) * 2006-04-18 2008-03-05 河北师范大学 棕点湍蛙抗微生物多肽及其在制药中的应用
JP6199033B2 (ja) 2009-11-02 2017-09-20 ユニヴァーシティ オブ ワシントン 治療用ヌクレアーゼ組成物および方法
IL300276B2 (en) 2011-04-29 2024-11-01 Univ Washington Therapeutic nuclease compositions and methods
HRP20192080T1 (hr) 2013-10-31 2020-02-07 Resolve Therapeutics, Llc Terapeutske fuzije nukleaza-albumine i postupci
US9919034B2 (en) 2014-03-28 2018-03-20 Tamir Biotechnology, Inc. Methods of treating and prophylactically protecting mammalian patients infected by viruses classified in Baltimore group V
CA2942706C (en) 2014-03-28 2020-01-14 Tamir Biotechnology, Inc. Rnase for use in treating or preventing viral infections
US9642794B2 (en) 2014-08-18 2017-05-09 Tamir Biotechnology, Inc. Antiviral pharmaceutical for topical administration
US10835598B2 (en) 2014-08-18 2020-11-17 Orgenesis Inc. Prophylactic protection against viral infections, particularly HIV
CN117159694A (zh) 2015-06-15 2023-12-05 塔米尔生物技术公司 用于治疗眼睛的病毒性感染的药物
US9682130B2 (en) 2015-09-25 2017-06-20 Okogen, Llc Viral conjunctivitis treatment using Ranpirnase and/or Amphinase
WO2017142807A1 (en) 2016-02-16 2017-08-24 Tamir Biotechnology, Inc. Treatment or prevention of zika virus infections by administration of a ribonuclease
AU2017290389B2 (en) 2016-07-01 2024-09-26 Resolve Therapeutics, Llc Optimized binuclease fusions and methods
WO2018022774A1 (en) 2016-07-26 2018-02-01 Squiquera Luis Prophylactic protection against viral infections
US11331378B2 (en) 2016-07-26 2022-05-17 Orgenesis Inc. Prophylactic protection against viral infections
BR112020003670A2 (pt) 2017-08-22 2020-09-01 Sanabio, Llc receptores de interferon solúveis e usos dos mesmos

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4882421A (en) * 1982-09-23 1989-11-21 Alfacell Corporation Pharmaceutical for treating tumors and method for making it
US5728805A (en) * 1988-04-06 1998-03-17 Alfacell Corp. Pharmaceuticals and method for making them
US5559212A (en) * 1988-04-06 1996-09-24 Alfacell Corporation Frog embryo and egg-derived tumor cell anti-proliferation protein
JP2972334B2 (ja) * 1989-11-13 1999-11-08 アルフアセル・コーポレイシヨン 精製された蛋白質および生物活性治療薬
AU726379B2 (en) * 1996-02-21 2000-11-02 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Recombinant ribonuclease proteins

Also Published As

Publication number Publication date
US6239257B1 (en) 2001-05-29
JP2002534075A (ja) 2002-10-15
WO2000040608A1 (en) 2000-07-13
EP1141004B1 (de) 2009-06-10
EP1141004A1 (de) 2001-10-10
DE69940980D1 (de) 2009-07-23
JP4516216B2 (ja) 2010-08-04

Similar Documents

Publication Publication Date Title
ATE433461T1 (de) Rana pipiens proteine und deren verwendung in der behandlung von tumoren
ATE349428T1 (de) Prostaglandinagoniste und deren verwendung zur behandlung von knochenerkrankungen
BR9811956B1 (pt) naftiridinonas e composição farmacêutica compreendendo as mesmas.
ATE198050T1 (de) Therapeutische anwendungen von bpi-protein- produkten zur behandlung von humaner meningococcämia
DE69826695D1 (de) Arylharnstoffderivate zur behandlung von inflammatorischen oder immunomodulatorischen erkrankungen
ATE362766T1 (de) Apolipoprotein a-i agonisten sowie deren verwendung zur behandlung dislipidemischer erkrankungen
DE69435096D1 (de) Zusammensetzung zur in vivo erzeugung von therapeutischen produkten
ATE222769T1 (de) Verabreichung von gm-csf zur behandlung der gehirntumoren und verhütung deren wiederauftretens
DE69631478D1 (de) Verwendung von vitamin d4-derivaten zur behandlung von hauterkrankungen
DE69333931D1 (de) Verwendung von Krillenzymen zur Behandlung von Zahnbelag
IL187254A (en) ANTISENSE NUCLEOTIDES, COMPOSITIONS COMPRISING THEREOF AND THEIR USE IN MODULATING ACTIVATION OF NF-kB
DE69738045D1 (de) Verwendung von cetrorelix zur behandlung von benigne prostatahypertrophie und prostatakrebs
EP1053315A4 (de) Menschliches 'haarlos'-gen und -protein und ihre verwendungen
ATE382061T1 (de) Mittel zur induktion von apoptosis und zur therapieanwendung
DE69431046D1 (de) Rekombinante adenoviren und deren verwendung in der gentherapie zur behandlung von augenerkrankungen
ATE287722T1 (de) Mittel zur behandlung maligner erkrankungen unter verwendung des proteins yb-1
DE69534633D1 (de) Implantat und vektor zur behandlung von erworbenen krankheiten
ATE313561T1 (de) Vgf polypeptide und verfahren zur behandlung von vgf-erkrankungen
DE69626816D1 (de) Verwendung von selegilin zur behandlung von gehörverlust bei säugetieren
PT782630E (pt) Gene da doenca poliquistica do rim
DE60017924D1 (de) Rekombinante, adenovirale vektoren und ihre verwendung zur behandlung von leberzirrhose
ID23184A (id) Garam-garam peptida bpc dengan aktivitas organoprotektif proses pembuatan dan penggunaannya dalam terapi
DE69916829D1 (de) Genetisch veränderte fibroblasten und ihre verwendung
ATE210126T1 (de) 4-amino-6-substituierte mycophenolsäurederivate mit immunsuppressiver wirkung
ATE238796T1 (de) Nukleosidderivative in kombinationspräparaten zur behandlung von hsv krankheiten

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties